Development and Validation of a Sensitive UHPLC–MS/MS Method for the Simultaneous Determination of 19 Bile Acids in Liver and Feces: Application to Metabolic Dysfunction‐Associated Steatotic Liver Disease Mice
Journal of Separation Science · 2026-05 · 49 (5)
DOI: 10.1002/jssc.70430 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Separation Science, online erschienen am 02.05.2026. Verfasst von Meng Xiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Bile Acids and Salts, Liver, Feces, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Recently, bile acids (BAs) have garnered significant attention due to their crucial roles in various metabolic diseases. However, the simultaneous quantification of BAs in biological samples is challenging due to the structural similarities, complex biological matrix, and tissue‐specific distribution. We developed a sensitive UHPLC–MS/MS method for quantitation of 19 BAs in mouse liver (mainly conjugated BAs) and feces (mainly unconjugated BAs). We compared protein precipitation, liquid–liquid extraction, and solid‐phase extraction (SPE) methods for sample preparation, and SPE was chosen due to the low background noise and high extraction efficiency for both conjugated and unconjugated BAs. The method was extensively validated by evaluating the linearity ( R 2 ≥ 0.991), extraction recovery (82%–112%), limits of detection (1–2 ng/mL) and low limits of quantification (2–5 ng/mL). Then, the method was applied to the detection of BAs in liver and feces of metabolic dysfunction‐associated steatotic liver disease mice, and the correlations between BA levels and the mRNA expression levels of BA metabolic enzymes, transporters, and receptors were analyzed. This study provides a direct and reliable determination method for the in‐depth investigation of the enterohepatic circulation of BAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
- National Institutes for Food and Drug Control, Beijing, China.
- Clinical Research Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
- Core Facilities Center, Capital Medical University, Beijing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xiao, M., Zhao, W., Ba, Y., Xia, M., Luo, K., You, L., Li, X., Zan, K., & Chen, X. (2026). Development and Validation of a Sensitive UHPLC–MS/MS Method for the Simultaneous Determination of 19 Bile Acids in Liver and Feces: Application to Metabolic Dysfunction‐Associated Steatotic Liver Disease Mice. Journal of Separation Science, 49(5). https://doi.org/10.1002/jssc.70430
Vancouver
Xiao M, Zhao W, Ba Y, Xia M, Luo K, You L, et al. Development and Validation of a Sensitive UHPLC–MS/MS Method for the Simultaneous Determination of 19 Bile Acids in Liver and Feces: Application to Metabolic Dysfunction‐Associated Steatotic Liver Disease Mice. Journal of Separation Science. 2026;49(5). doi:10.1002/jssc.70430
BibTeX
@article{Xiao2026,
author = {Xiao, Meng and Zhao, Wenwen and Ba, Yinying and Xia, Miao and Luo, Kui and You, Longtai and Li, Xiao and Zan, Ke and Chen, Xiaoqing},
title = {Development and Validation of a Sensitive UHPLC–MS/MS Method for the Simultaneous Determination of 19 Bile Acids in Liver and Feces: Application to Metabolic Dysfunction‐Associated Steatotic Liver Disease Mice},
journal = {Journal of Separation Science},
year = {2026},
volume = {49},
number = {5},
doi = {10.1002/jssc.70430}
}
EUVIMED